SensoDetect AB

SensoDetect operates in the healthcare sector. The company specializes in developing medical equipment that is used to analyze how a patient's brain reacts to sound stimuli. The technology is used in psychiatry to distinguish potential mental illnesses. The product consists of electrodes that are attached to the patient's head and then analyze brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is headquartered in Lund.

Quotes for SensoDetect AB

Right Now

+/-
-0.0012
%
−27,27%
Latest
0.0032
High
0.006
Low
0.0026
Volume
58 103 067
Turnover (SEK)
194 860
Market Value (MSEK)
1,4
Time (Latest trade)

Board

CEO

  • Per-Anders Hedin

Chairperson of the Board

  • Karl Lundin

Board

  • Hu Jin
  • Johan Peter Morgan Friberg
  • Wendi Ma
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    SensoDetect - Stora Aktiedagarna Stockholm 28 november 2024

    SensoDetect

    SensoDetect - Presentation BioStock Live - 2018-11-27

    SensoDetect AB intervju

    Insider trading

    *Powered by Modular Finance

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2026-06-13

    • 2026-08-29 Interim Report 2026-Q2

    • 2026-11-13 Interim Report 2026-Q3

    • 2027-02-19 Year End Report 2026

    • 2027-05-28 Annual General Meeting 2026

    Annual reports, prospectus etc.